CVS Health (NYSE:CVS) is set to give its latest quarterly earnings report on Tuesday, 2026-02-10. Here’s what investors need to know before the announcement.
Analysts estimate that CVS Health will report an earnings per share (EPS) of $0.99.
Investors in CVS Health are eagerly awaiting the company’s announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It’s worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
Earnings History Snapshot
In the previous earnings release, the company beat EPS by $0.24, leading to a 4.85% drop in the share price the following trading session.
Here’s a look at CVS Health’s past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | 1.36 | 1.47 | 1.70 | 0.933 |
| EPS Actual | 1.60 | 1.81 | 2.25 | 1.190 |
| Price Change % | -5.00 | 1.00 | -3.00 | 5.000 |
Tracking CVS Health’s Stock Performance
Shares of CVS Health were trading at $78.35 as of February 06. Over the last 52-week period, shares are up 42.45%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
Analysts’ Take on CVS Health
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on CVS Health.
Analysts have provided CVS Health with 13 ratings, resulting in a consensus rating of Outperform. The average one-year price target stands at $94.62, suggesting a potential 23.96% …